GSA CAPITAL PARTNERS LLP - RAPT THERAPEUTICS INC ownership

RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 86 filers reported holding RAPT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.3%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of RAPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$510
-22.4%
30,716
-12.6%
0.04%
-33.3%
Q2 2023$657
+18.0%
35,140
+15.7%
0.07%
+20.0%
Q1 2023$557
-99.9%
30,362
-19.9%
0.06%
-54.5%
Q3 2022$912,000
+349.3%
37,891
+240.7%
0.12%
+303.3%
Q2 2022$203,000
-51.2%
11,121
-41.2%
0.03%
-46.4%
Q1 2022$416,000
+28.8%
18,915
+115.3%
0.06%
+36.6%
Q4 2021$323,000
-68.9%
8,784
-73.7%
0.04%
-61.3%
Q3 2021$1,038,00033,4230.11%
Other shareholders
RAPT THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Column Group LLC 2,680,621$49,189,39517.79%
Euclidean Capital LLC 432,900$7,943,7156.97%
GREAT POINT PARTNERS LLC 1,355,151$24,867,0214.88%
KINGDON CAPITAL MANAGEMENT, L.L.C. 875,984$16,074,3063.02%
Trustees of Columbia University in the City of New York 80,580$1,478,6432.64%
Perceptive Advisors 2,291,608$42,051,0071.24%
Cormorant Asset Management, LP 650,000$11,9280.79%
Alphabet Inc. 540,270$9,913,9550.55%
Redmile Group, LLC 688,132$12,627,2220.55%
Orbimed Advisors 1,251,070$22,957,1350.45%
View complete list of RAPT THERAPEUTICS INC shareholders